Skin penetration/permeation enhancers are compounds that improve (trans)dermal drug delivery. We designed hybrid terpene-amino acid enhancers by conjugating natural terpenes (citronellol, geraniol, nerol, farnesol, linalool, perillyl alcohol, menthol, borneol, carveol) or cinnamyl alcohol with 6-(dimethylamino)hexanoic acid through a biodegradable ester linker. The compounds were screened for their ability to increase the delivery of theophylline and hydrocortisone through and into human skin ex vivo. The citronellyl, bornyl and cinnamyl esters showed exceptional permeation-enhancing properties (enhancement ratios up to 82) while having low cellular toxicities. The barrier function of enhancer-treated skin (assessed by transepidermal water loss and electrical impedance) recovered within 24 h. Infrared spectroscopy suggested that these esters fluidized the stratum corneum lipids. Furthermore, the citronellyl ester increased the epidermal concentration of topically applied cidofovir, which is a potent antiviral and anticancer drug, by 15-fold. In conclusion, citronellyl 6-(dimethylamino)hexanoate is an outstanding enhancer with an advantageous combination of properties, which may improve the delivery of drugs that have a limited ability to cross biological barriers.

Department of Biochemical Sciences Charles University Faculty of Pharmacy in Hradec Králové Akademika Heyrovského 1203 50005 Hradec Králové Czech Republic

Department of Organic and Bioorganic Chemistry Charles University Faculty of Pharmacy in Hradec Králové Akademika Heyrovského 1203 50005 Hradec Králové Czech Republic

Skin Barrier Research Group Charles University Faculty of Pharmacy in Hradec Králové Akademika Heyrovského 1203 50005 Hradec Králové Czech Republic

Zobrazit více v PubMed

Brown MB, Martin GP, Jones SA, Akomeah FK. Dermal and transdermal drug delivery systems: current and future prospects. Drug Deliv. 2006;13:175–187. doi: 10.1080/10717540500455975. PubMed DOI

Prausnitz MR, Mitragotri S, Langer R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discovery. 2004;3:115–124. doi: 10.1038/nrd1304. PubMed DOI

Menon G, Kligman A. Barrier functions of human skin: a holistic view. Skin Pharmacol Physiol. 2009;22:178–189. doi: 10.1159/000231523. PubMed DOI

Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci. 2001;14:101–114. doi: 10.1016/S0928-0987(01)00167-1. PubMed DOI

Asbill CS, Michniak BB. Percutaneous penetration enhancers: local versus transdermal activity. Pharm Sci Technol Today. 2000;3:36–41. doi: 10.1016/S1461-5347(99)00225-4. PubMed DOI

Barry BW. Action of skin penetration enhancers-the Lipid Protein Partitioning theory. Int J Cosmet Sci. 1988;10:281–293. doi: 10.1111/j.1467-2494.1988.tb00028.x. PubMed DOI

Suhonen TM, Bouwstra JA, Urtti A. Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations. J Control Release. 1999;59:149–161. doi: 10.1016/S0168-3659(98)00187-4. PubMed DOI

Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev. 2012;64:128–137. doi: 10.1016/j.addr.2012.09.032. PubMed DOI

Thomas BJ, Finnin BC. The transdermal revolution. Drug Discovery Today. 2004;9:697–703. doi: 10.1016/S1359-6446(04)03180-0. PubMed DOI

Janůšová B, et al. Amino acid derivatives as transdermal permeation enhancers. J Control Release. 2013;165:91–100. doi: 10.1016/j.jconrel.2012.11.003. PubMed DOI

Novotný J, et al. Dimethylamino acid esters as biodegradable and reversible transdermal permeation enhancers: effects of linking chain length, chirality and polyfluorination. Pharm Res. 2009;26:811–821. doi: 10.1007/s11095-008-9780-3. PubMed DOI

López A, Llinares F, Cortell C, Herraez M. Comparative enhancer effects of Span® 20 with Tween® 20 and Azone® on the in vitro percutaneous penetration of compounds with different lipophilicities. Int J Pharm. 2000;202:133–140. doi: 10.1016/S0378-5173(00)00427-0. PubMed DOI

Kopečná M, et al. Dodecyl Amino Glucoside Enhances Transdermal and Topical Drug Delivery via Reversible Interaction with Skin Barrier Lipids. Pharm Res. 2017;34:640–653. doi: 10.1007/s11095-016-2093-z. PubMed DOI

Kopečná M, et al. Galactosyl Pentadecene Reversibly Enhances Transdermal and Topical Drug Delivery. Pharm Res. 2017;34:2097–2108. doi: 10.1007/s11095-017-2214-3. PubMed DOI

Hirvonen J, Sutinen R, Paronen P, Urtti A. Transdermal penetration enhancers in rabbit pinna skin: duration of action, skin irritation, and in vivo/in vitro comparison. Int J Pharm. 1993;99:253–261. doi: 10.1016/0378-5173(93)90368-P. DOI

Rambharose S, Kalhapure RS, Jadhav M, Govender T. Exploring unsaturated fatty acid cholesteryl esters as transdermal permeation enhancers. Drug Deliv Translat Res. 2017;7:333–345. doi: 10.1007/s13346-017-0360-0. PubMed DOI

Wang M, et al. l-Carvyl esters as penetration enhancers for the transdermal delivery of 5-fluorouracil. AAPS PharmSciTech. 2013;14:669–674. doi: 10.1208/s12249-013-9952-2. PubMed DOI PMC

Vávrová, K. & Hrabálek, A. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement 325–336 (Springer, 2015).

Aqil M, Ahad A, Sultana Y, Ali A. Status of terpenes as skin penetration enhancers. Drug Discov Today. 2007;12:1061–1067. doi: 10.1016/j.drudis.2007.09.001. PubMed DOI

Sapra B, Jain S, Tiwary A. Percutaneous permeation enhancement by terpenes: mechanistic view. AAPS J. 2008;10:120. doi: 10.1208/s12248-008-9012-0. PubMed DOI PMC

Takada H, et al. Effect of various vehicles on skin permeation of ondansetron hydrochloride, and their mechanism of permeation enhancement. Asian J Pharm Sci. 2009;4:81–88.

Godwin D, Michniak B. Influence of drug lipophilicity on terpenes as transdermal penetration enhancers. Drug Dev Ind Pharm. 1999;25:905–915. doi: 10.1081/DDC-100102251. PubMed DOI

Vaddi H, Ho P, Chan S. Terpenes in propylene glycol as skin‐penetration enhancers: Permeation and partition of haloperidol, fourier transform infrared spectroscopy, and differential scanning calorimetry. J Pharm Sci. 2002;91:1639–1651. doi: 10.1002/jps.10160. PubMed DOI

Yi Q-F, Yan J, Tang S-Y, Huang H, Kang L-Y. Effect of borneol on the transdermal permeation of drugs with differing lipophilicity and molecular organization of stratum corneum lipids. Drug Dev Industrial Pharm. 2016;42:1086–1093. doi: 10.3109/03639045.2015.1107095. PubMed DOI

Fang JY, Hung CF, Chiu HC, Wang JJ, Chan TF. Efficacy and irritancy of enhancers on the in‐vitro and in‐vivo percutaneous absorption of curcumin. Journal of pharmacy and pharmacology. 2003;55:593–601. doi: 10.1211/002235703765344496. PubMed DOI

Fujii M, et al. Comparison of skin permeation enhancement by 3-l-menthoxypropane-1,2-diol and l-menthol: the permeation of indomethacin and antipyrine through Yucatan micropig skin and changes in infrared spectra and X-ray diffraction patterns of stratum corneum. Int J Pharm. 2003;258:217–223. doi: 10.1016/S0378-5173(03)00205-9. PubMed DOI

Rizwan M, Aqil M, Ahad A, Sultana Y, Ali MM. Transdermal delivery of valsartan: I. Effect of various terpenes. Drug Dev Ind Pharm. 2008;34:618–626. doi: 10.1080/03639040701833740. PubMed DOI

Kang L, et al. SMGA gels for the skin permeation of haloperidol. J Control Release. 2005;106:88–98. doi: 10.1016/j.jconrel.2005.04.017. PubMed DOI

Vávrová K, Lorencová K, Novotný J, Holý A, Hrabálek A. Permeation enhancer dodecyl 6-(dimethylamino) hexanoate increases transdermal and topical delivery of adefovir: influence of pH, ion-pairing and skin species. Eur J Pharm Biopharm. 2008;70:901–907. doi: 10.1016/j.ejpb.2008.07.002. PubMed DOI

Diblíková D, et al. Transdermal delivery and cutaneous targeting of antivirals using a penetration enhancer and lysolipid prodrugs. Pharm Res. 2014;31:1071–1081. doi: 10.1007/s11095-013-1228-8. PubMed DOI

Wu P-C, Chang J-S, Huang Y-B, Chai C-Y, Tsai Y-H. Evaluation of percutaneous absorption and skin irritation of ketoprofen through rat skin: in vitro and in vivo study. Int J Pharm. 2001;222:225–235. doi: 10.1016/S0378-5173(01)00707-4. PubMed DOI

Bickers D, et al. A toxicologic and dermatologic assessment of cinnamyl alcohol, cinnamaldehyde and cinnamic acid when used as fragrance ingredients: The RIFM expert panel. Food Chem Toxicol. 2005;43:799–836. doi: 10.1016/j.fct.2004.09.013. PubMed DOI

Scheuplein R, Blank I, Brauner G, Macfarlane DJ. Percutaneous absorption of steroids. J Invest Dermatol. 1969;52:63–70. doi: 10.1038/jid.1969.9. PubMed DOI

Morimoto K, Tojima H, Haruta T, Suzuki M, Kakemi M. Enhancing effects of unsaturated fatty acids with various structures on the permeation of indomethacin through rat skin. J Pharm Pharmacol. 1996;48:1133–1137. doi: 10.1111/j.2042-7158.1996.tb03908.x. PubMed DOI

Nokhodchi A, Sharabiani K, Rashidi MR, Ghafourian T. The effect of terpene concentrations on the skin penetration of diclofenac sodium. Int J Pharm. 2007;335:97–105. doi: 10.1016/j.ijpharm.2006.10.041. PubMed DOI

Narishetty STK, Panchagnula R. Transdermal delivery of zidovudine: effect of terpenes and their mechanism of action. J Control Release. 2004;95:367–379. doi: 10.1016/j.jconrel.2003.11.022. PubMed DOI

Arellano A, Santoyo S, Martin C, Ygartua P. Enhancing effect of terpenes on the in vitro percutaneous absorption of diclofenac sodium. Int J Pharm. 1996;130:141–145. doi: 10.1016/0378-5173(95)04364-0. DOI

Vavrova K, Zbytovska J, Hrabalek A. Amphiphilic transdermal permeation enhancers: structure-activity relationships. Curr Med Chem. 2005;12:2273–2291. doi: 10.2174/0929867054864822. PubMed DOI

Kopecna M, et al. Fluorescent Penetration Enhancers Reveal Complex Interactions among the Enhancer, Drug, Solvent, and Skin. Mol Pharm. 2019;16:886–897. doi: 10.1021/acs.molpharmaceut.8b01196. PubMed DOI

Berghe TV, et al. Determination of apoptotic and necrotic cell death in vitro and in vivo. Methods. 2013;61:117–129. doi: 10.1016/j.ymeth.2013.02.011. PubMed DOI

Grubauer G, Elias PM, Feingold KR. Transepidermal water loss: the signal for recovery of barrier structure and function. J Lipid Res. 1989;30:323–333. PubMed

Karande P, Jain A, Mitragotri S. Relationships between skin’s electrical impedance and permeability in the presence of chemical enhancers. J Control Release. 2006;110:307–313. doi: 10.1016/j.jconrel.2005.10.012. PubMed DOI

Löffler H, Happle R. Profile of irritant patch testing with detergents: sodium lauryl sulfate, sodium laureth sulfate and alkyl polyglucoside. Contact Dermatitis. 2003;48:26–32. doi: 10.1034/j.1600-0536.2003.480105.x. PubMed DOI

Boncheva M, Damien F, Normand V. Molecular organization of the lipid matrix in intact Stratum corneum using ATR-FTIR spectroscopy. Biochim Biophys Acta. 2008;1778:1344–1355. doi: 10.1016/j.bbamem.2008.01.022. PubMed DOI

Lin S-Y, Duan K-J, Lin T-C. Simultaneous determination of the protein conversion process in porcine stratum corneum after pretreatment with skin enhancers by a combined microscopic FT-IR/DSC system. Spectrochim Acta A Mol Biomol Spectrosc. 1996;52:1671–1678. doi: 10.1016/0584-8539(96)01722-9. DOI

Mendelsohn R, Flach CR, Moore DJ. Determination of molecular conformation and permeation in skin via IR spectroscopy, microscopy, and imaging. Biochim Biophys Acta. 2006;1758:923–933. doi: 10.1016/j.bbamem.2006.04.009. PubMed DOI

Moghadam SH, et al. Effect of chemical permeation enhancers on stratum corneum barrier lipid organizational structure and interferon alpha permeability. Mol Pharm. 2013;10:2248–2260. doi: 10.1021/mp300441c. PubMed DOI

Pham QD, Björklund S, Engblom J, Topgaard D, Sparr E. Chemical penetration enhancers in stratum corneum—Relation between molecular effects and barrier function. J Control Release. 2016;232:175–187. doi: 10.1016/j.jconrel.2016.04.030. PubMed DOI

Zabawski JE. A review of topical and intralesional cidofovir. Dermatol Online J. 2000;6:3–3. PubMed

De Clercq E, Holý A. Acyclic nucleoside phosphonates: a key class of antiviral drugs. Nat Rev Drug Discovery. 2005;4:928–940. doi: 10.1038/nrd1877. PubMed DOI

Bezrouk A, et al. SAMPA: A free software tool for skin and membrane permeation data analysis. Toxicol in Vitro. 2017;44:361–371. doi: 10.1016/j.tiv.2017.07.017. PubMed DOI

Kligman AM, Christophers E. Preparation of isolated sheets of human stratum corneum. Arch Dermatol. 1963;88:702–705. doi: 10.1001/archderm.1963.01590240026005. PubMed DOI

Time-Dependent Differences in the Effects of Oleic Acid and Oleyl Alcohol on the Human Skin Barrier

The Contest of Nanoparticles: Searching for the Most Effective Topical Delivery of Corticosteroids

Proline, hydroxyproline, and pyrrolidone carboxylic acid derivatives as highly efficient but reversible transdermal permeation enhancers

Phospholipid-Based Microemulsions for Cutaneous Imiquimod Delivery

N-Alkylmorpholines: Potent Dermal and Transdermal Skin Permeation Enhancers

Behavior of 1-Deoxy-, 3-Deoxy- and N-Methyl-Ceramides in Skin Barrier Lipid Models